InMode Stock Forecast
NASDAQ: INMDHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
INMD analyst consensus
Consensus (5 analysts)
none
Avg. price target
$16.17+13.79%
- Strong buy 0
- Buy 0
- Hold 5
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 5 Wall Street analysts covering InMode (2026-10-08), 0 rate the stock a buy or strong buy, 5 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $16.17, with a high estimate of $17.00 and a low estimate of $15.00. The average target implies upside of 13.8% from the current price of $14.21.
The spread between the highest and lowest targets is 13.3%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for INMD.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 0 | 0% |
| Hold | 5 | 100% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $15.00 | +5.56% |
| Average target | $16.17 | +13.79% |
| High target | $17.00 | +19.63% |